Ms Tanasha Robinson, | |
73080 Becky Rd, Covington, LA 70435-5864 | |
(504) 957-3037 | |
Not Available |
Full Name | Ms Tanasha Robinson |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 73080 Becky Rd, Covington, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053848804 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Tanasha Robinson, 73080 Becky Rd, Covington, LA 70435-5864 Ph: (504) 957-3037 | Ms Tanasha Robinson, 73080 Becky Rd, Covington, LA 70435-5864 Ph: (504) 957-3037 |
News Archive
Global scientific, technical, medical and scholarly publisher Wiley-Blackwell today announced the that its evidence-based clinical decision support product, Essential Evidence Plus, is now accessible from mobile devices. Physicians on the move can now easily find answers to challenging point-of-care questions from their iPhoneTM, IPod Touch-, AndroidTM, Blackberry- or other Smartphones.
Friday, January 8, 2010, the Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab), a new biologic response modifier for adult patients with moderately to severely active rheumatoid arthritis (RA).
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced that its CM-AT autism treatment, now in Phase III clinical trials, has been designated as a Fast Track drug by the U.S. Food and Drug Administration (FDA).
An international study led by scientists at Universit- de Montr-al and University of Oxford, has identified a gene associated with common migraines. Their findings show that a mutation in the KCNK18 gene inhibits the function of a protein called TRESK. TRESK normally plays a key role in nerve cell communication. Published today in Nature Medicine, this study may have implications for people who suffer from recurrent headaches, which include more than six million Canadians.
› Verified 5 days ago
Jessica Oddo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 31 Shady Oaks Dr, Covington, LA 70433 Phone: 504-224-0288 | |
Crystal Younger, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1016 1/2 W 21st Ave, Covington, LA 70433 Phone: 985-276-4165 | |
Dr. Christy Montgomery, ED.D, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 14 Pecan Grove Ct, Covington, LA 70433 Phone: 985-516-1395 | |
Dr. Donald James Waterman Jr., PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 5001 Highway 190 East Service Rd Ste C1, Covington, LA 70433 Phone: 985-626-8700 Fax: 985-892-2055 | |
Ms. Gina Francesca Greco, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4465 Highway 190 East Service Rd, Covington, LA 70433 Phone: 504-460-0289 | |
Ms. Dawn Brewer Ferrara, NCC, LPC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 312 S Jefferson Ave Ste B, Covington, LA 70433 Phone: 985-373-6000 | |
Latoya Williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 19295 N 3rd St Ste 2, Covington, LA 70433 Phone: 985-400-5901 Fax: 985-400-5164 |